New Canadian consensus guidelines for pharmacist prescribing of naloxoneAll patients receiving an opioid should be provided with take-home naloxone and counselled by a pharmacist New Canadian statement on management of pulmonary hypertensionJoint Canadian Cardiovascular Society–Canadian Thoracic Society statement outlines current approach to diagnosis and management of pulmonary hypertension First Canadian guidance document on management of syncope Canadian Cardiovascular Society issues first clinical practice guideline on assessment and management of syncope 2020/2021 Canadian influenza guidelines now available Annual update provides comprehensive information on influenza, recommended vaccine recipients, available vaccines and choice of vaccine 2020 Canadian hypertension guidelines now available, with separate guidelines for managing resistant cases Provide expert guidance on the prevention, diagnosis, risk assessment and treatment of hypertension in adults and children Canadian interim guidelines for managing patients with moderate to severe COVID-19 Provide advice on timely, effective and safe supportive management of adults and children with suspected or confirmed COVID-19 'Housing is medicine': CMAJ publishes new clinical guideline on homelessness The guideline aims to inform clinicians on evidence-based interventions to treat homeless International Pharmaceutical Federation releases international guidelines on coronavirus for pharmacists The document outlines preventive measures , what equipment to stock, and advice pharmacists can give to patients Canadian recommendations for use of newer meningococcal B vaccine, Trumenba The two meningococcal serogroup B vaccines available in Canada are not interchangeable New British guidelines on managing inflammatory bowel disease in adults Provide updated guidance on pharmacologic, nonpharmacologic and surgical interventions for ulcerative colitis and Crohn’s disease First Previous 5 6 7 8 9 Next Last
